Company intelligence / Profile preview

Åmic AB

Uppsala, Uppsala County, Sweden

Ownership: Private
Development stage: Other

Overview

Åmic developed innovative low-cost, high precision molded polymer parts for use in point-of-care diagnostics. The company shifted from being a technology incubator to a product-focused business targeting the diagnostic market with OEM solutions. It was acquired in 2008 by a major IVD player and subsequently became part of GE Healthcare. The original Swedish site has since been closed, with the technology transferred abroad. No current independent clinical results as the company no longer operates independently.

Therapeutic areas: Other
Modalities: Diagnostic platforms based on polymer microfluidics and surface chemistry for point-of-care testing
Industry: Chemicals & Materials

Partnerships

Biacore AB/Pharmacia Biotech/Toolex Alpha/Lynx Therapeutics were historical collaborators or stakeholders during different phases of the core technology's development.

Beyond the preview

Go deeper on Åmic AB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Åmic AB.